Company mentioned on podcasts
Candid Therapeutics
Mentioned on 1 episode by 1 guest across our covered podcasts.
SignalCast may earn commission on purchases via these links.
Who mentioned it
- Ken SongAuthor
“Ken Song, CEO of Candid Therapeutics, explains how bispecific T-cell engaging antibodies could deliver CAR-T-like immune resets for autoimmune diseases at scale. The San Diego startup raised $370M, licensed two clinical-stage assets from China, and has now treated over 60 autoimmune patients across 10 disease indications in under 18 months.”
Mentioned on: The Long Run with Luke Timmerman